# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Tonix Pharmaceuticals secures a potential $34 million agreement with the Defense Threat Reduction Agency to develop antiviral a...
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as fo...
Company aligned with FDA on key CMC topicsTonix also has completed the second and final pre-New Drug Application (NDA) meeting ...